Search Results - "Taiar, Ivan"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Effect of a 10-day transcutaneous trigeminal nerve stimulation (TNS) protocol for depression amelioration: A randomized, double blind, and sham-controlled phase II clinical trial by Generoso, Marcelo B., Taiar, Ivan T., Garrocini, Lucas P., Bernardon, Rafael, Cordeiro, Quirino, Uchida, Ricardo R., Shiozawa, Pedro

    Published in Epilepsy & behavior (01-06-2019)
    “…Major depressive disorder (MDD) is one of the leading causes of disability in the world. However, treatment options are still limited, and marked by high…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Cariprazine for treating psychosis: an updated meta-analysis by Generoso, Marcelo B, Taiar, Ivan, Cordeiro, Quirino, Shiozawa, Pedro, Kasper, Siegfried

    “…Early treatment of psychotic illness improves outcomes, reduces relapse rates and should not be delayed. Cariprazine is a promising antipsychotic drug and may…”
    Get full text
    Journal Article
  6. 6

    Effect of a 10-day trigeminal nerve stimulation (TNS) protocol for treating major depressive disorder: A phase II, sham-controlled, randomized clinical trial by Shiozawa, Pedro, da Silva, Mailu Enokibara, Netto, Geraldo Teles Machado, Taiar, Ivan, Cordeiro, Quirino

    Published in Epilepsy & behavior (01-03-2015)
    “…Abstract Background Considering both the burden determined by major depressive disorder (MDD) itself and the high refractoriness and recurrence index,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Cariprazine for treating psychosis: an updated meta-analysis by Generoso, Marcelo B., Taiar, Ivan, Cordeiro, Quirino, Shiozawa, Pedro, Kasper, Siegfried

    “…Early treatment of psychotic illness improves outcomes, reduces relapse rates and should not be delayed. Cariprazine is a promising antipsychotic drug and may…”
    Get full text
    Report
  19. 19